The better prognosis in breast, lung and ovarian cancer patient with higher ACSL5 expression was in accordance with the result from Oncomine and PrognoScan database, implying the tumor suppressor role of ACSL5 in breast, lung and ovarian cancer (Fig 6I–6K). Here, ACSL5 is linked to neoplasm.